Primary Site >> Stomach Cancer
Gene >> YAP1
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. PMID: 18175224 |
Ref: Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. PMID: 19424602 Ref: Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. PMID: 19705503 |
Ref: Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. PMID: 21346147 Ref: Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line. PMID: 21805037 Ref: RNA interference mediated YAP gene silencing inhibits invasion and metastasis of human gastric cancer cell line SGC-7901. PMID: 22024089 |
Ref: Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer. PMID: 22993325 Ref: Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis. PMID: 23058008 Ref: Function and cancer genomics of FAT family genes (review). PMID: 23076869 Ref: Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer. PMID: 23298488 |
Ref: 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway. PMID: 24008339 Ref: Effects of the hippo signaling pathway in human gastric cancer. PMID: 24175801 |
Ref: Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer. PMID: 24325916 Ref: Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma. PMID: 24643316 Ref: Inhibitory effects of dobutamine on human gastric adenocarcinoma. PMID: 25493021 |
Ref: VGLL4 inhibits EMT in part through suppressing Wnt/beta-catenin signaling pathway in gastric cancer. PMID: 25701461 Ref: MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1. PMID: 25846731 Ref: Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein. PMID: 25971581 Ref: miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells. PMID: 26045994 Ref: Molecular biomarkers in gastric cancer. PMID: 26052595 Ref: Optimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells. PMID: 26168187 Ref: PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. PMID: 26431277 |
Ref: Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells. PMID: 26575609 Ref: Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway. PMID: 26840256 Ref: Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling. PMID: 26921249 Ref: LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and beta-catenin. PMID: 26936013 Ref: siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice. PMID: 27073556 Ref: Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma. PMID: 27325246 Ref: Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer. PMID: 27654712 Ref: YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo. PMID: 27835600 |
Ref: RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3. PMID: 27425596 Ref: Roles of RUNX in Hippo Pathway Signaling. PMID: 28299672 Ref: DNA-binding mechanism of the Hippo pathway transcription factor TEAD4. PMID: 28368398 Ref: Distinct prognostic values of YAP1 in gastric cancer. PMID: 28381174 Ref: YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis. PMID: 28538170 Ref: WWC3 downregulation correlates with poor prognosis and inhibition of Hippo signaling in human gastric cancer. PMID: 28652775 Ref: TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. PMID: 28759040 Ref: YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression. PMID: 28848999 Ref: Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer. PMID: 28885730 Ref: Obesity accelerates murine gastric cancer growth by modulating the Sirt1/YAP pathway. PMID: 28943922 Ref: Identification of a novel YAP-14-3-3zeta negative feedback loop in gastric cancer. PMID: 29069755 Ref: Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients. PMID: 29113304 Ref: Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer. PMID: 29296196 |
Ref: Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells. PMID: 29097184 Ref: Targeting IRF3 as a YAP agonist therapy against gastric cancer. PMID: 29339449 Ref: miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis. PMID: 29367737 Ref: Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy. PMID: 29402328 Ref: Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy. PMID: 29436693 Ref: The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition. PMID: 29535422 Ref: YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. PMID: 29669762 Ref: Epigenetic silencing of miR-1271 enhances MEK1 and TEAD4 expression in gastric cancer. PMID: 29862663 Ref: Expression of VGLL4 and YAP protein in gastric carcinoma tissues and its relationship with prognosis of gastric carcinoma. PMID: 29914241 Ref: Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells. PMID: 30021363 Ref: VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs. PMID: 30034932 Ref: Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 (VGLL4) binding to TEA domain transcription factor 4 (TEAD4) by molecular dynamics simulation and molecular mechanics generalized Born/surface area (M PMID: 30051771 Ref: PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. PMID: 30134988 Ref: Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer. PMID: 30180862 Ref: LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway. PMID: 30297104 Ref: Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 (Kip1) axis. PMID: 30336780 Ref: LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1. PMID: 30349368 |